Literature DB >> 17467020

Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase.

R Kaushik1, Clint A Rosenfeld, L G Sultatos.   

Abstract

For many decades it has been thought that oxygen analogs (oxons) of organophosphorus insecticides phosphorylate the catalytic site of acetylcholinesterase by a mechanism that follows simple Michaelis-Menten kinetics. More recently, the interactions of at least some oxons have been shown to be far more complex and likely involve binding of oxons to a second site on acetylcholinesterase that modulates the inhibitory capacity of other oxon molecules at the catalytic site. The current study has investigated the interactions of chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase. Both chlorpyrifos oxon and methyl paraoxon were found to have k(i)'s that change as a function of oxon concentration. Furthermore, 10 nM chlorpyrifos oxon resulted in a transient increase in acetylthiocholine hydrolysis, followed by inhibition. Moreover, in the presence of 100 nM chlorpyrifos oxon, acetylthiocholine was found to influence both the K(d) (binding affinity) and k(2) (phosphorylation constant) of this oxon. Collectively, these results demonstrate that the interactions of chlorpyrifos oxon and methyl paraoxon with acetylcholinesterase cannot be described by simple Michaelis-Menten kinetics but instead support the hypothesis that these oxons bind to a secondary site on acetylcholinesterase, leading to activation/inhibition of the catalytic site, depending on the nature of the substrate and inhibitor. Additionally, these data raise questions regarding the adequacy of estimating risk of low levels of insecticide exposure from direct extrapolation of insecticide dose-response curves since the capacity of individual oxon molecules at low oxon levels could be greater than individual oxon molecules in vivo associated with the dose-response curve.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467020      PMCID: PMC2034337          DOI: 10.1016/j.taap.2007.03.013

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  27 in total

1.  Exploration of the Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-100) and mutated enzymes.

Authors:  V Marcel; S Estrada-Mondaca; F Magné; J Stojan; A Klaébé; D Fournier
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

2.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

3.  Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.

Authors:  T Szegletes; W D Mallender; P J Thomas; T L Rosenberry
Journal:  Biochemistry       Date:  1999-01-05       Impact factor: 3.162

4.  A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesterase.

Authors:  J Stojan; V Marcel; S Estrada-Mondaca; A Klaebe; P Masson; D Fournier
Journal:  FEBS Lett       Date:  1998-11-27       Impact factor: 4.124

5.  Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics.

Authors:  F Worek; C Diepold; P Eyer
Journal:  Arch Toxicol       Date:  1999-02       Impact factor: 5.153

Review 6.  Quantal acetylcholine release at the vertebrate neuromuscular junction.

Authors:  W Van der Kloot; J Molgó
Journal:  Physiol Rev       Date:  1994-10       Impact factor: 37.312

7.  The influence of peripheral site ligands on the reaction of symmetric and chiral organophosphates with wildtype and mutant acetylcholinesterases.

Authors:  Z Radić; P Taylor
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

8.  Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon.

Authors:  Clint A Rosenfeld; Lester G Sultatos
Journal:  Toxicol Sci       Date:  2006-01-10       Impact factor: 4.849

9.  Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway.

Authors:  W D Mallender; T Szegletes; T L Rosenberry
Journal:  Biochemistry       Date:  2000-07-04       Impact factor: 3.162

Review 10.  Common mechanism of toxicity: a case study of organophosphorus pesticides.

Authors:  B E Mileson; J E Chambers; W L Chen; W Dettbarn; M Ehrich; A T Eldefrawi; D W Gaylor; K Hamernik; E Hodgson; A G Karczmar; S Padilla; C N Pope; R J Richardson; D R Saunders; L P Sheets; L G Sultatos; K B Wallace
Journal:  Toxicol Sci       Date:  1998-01       Impact factor: 4.849

View more
  6 in total

1.  Comparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase.

Authors:  Alper Coban; Russell L Carr; Howard W Chambers; Kenneth O Willeford; Janice E Chambers
Journal:  Toxicol Lett       Date:  2016-03-07       Impact factor: 4.372

2.  Chlorpyrifos and chlorpyrifos oxon impair the transport of membrane bound organelles in rat cortical axons.

Authors:  Jie Gao; Sean X Naughton; Wayne D Beck; Caterina M Hernandez; Guangyu Wu; Zhe Wei; Xiangkun Yang; Michael G Bartlett; Alvin V Terry
Journal:  Neurotoxicology       Date:  2017-06-12       Impact factor: 4.294

3.  An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon.

Authors:  Josephine Shenouda; Paula Green; Lester Sultatos
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-19       Impact factor: 4.219

4.  Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.

Authors:  Shensheng Zhao; Sebastiaan Wesseling; Bert Spenkelink; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2021-03-14       Impact factor: 5.153

5.  Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.

Authors:  Isaac Omwenga; Shensheng Zhao; Laetitia Kanja; Hans Mol; Ivonne M C M Rietjens; Jochem Louisse
Journal:  Arch Toxicol       Date:  2021-03-02       Impact factor: 5.153

6.  Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome cytochromes P450 (CYP)-specific kinetic data as model input.

Authors:  Shensheng Zhao; Sebastiaan Wesseling; Ivonne M C M Rietjens; Marije Strikwold
Journal:  Arch Toxicol       Date:  2022-03-16       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.